Vitiligo
Vitiligo
Vitiligo is an autoimmune condition which results in the loss of melanocytes and consequent depigmentation of the skin. It is thought to affect around 1% of the population and symptoms typically develop by the age of 20-30 years.
Last updated: 23
rd
May 2023
Epidemiology
Incidence: 20.00 cases per 100,000 person-years
Peak incidence: 20-30 years
Sex ratio: 1:1
<1
1-5
6+
16+
30+
40+
50+
60+
70+
80+
Aetiology
Associated conditions
Type 1 diabetes mellitus
Addison's disease
Autoimmune thyroid disorders
Pernicious anaemia
Alopecia areata
Improve
Clinical features
- Well-demarcated patches of depigmented skin
The peripheries tend to be most affected
Trauma may precipitate new lesions (Koebner phenomenon)
Improve
Management
- Sunblock for affected areas of skin
Camouflage make-up
Topical corticosteroids may reverse the changes if applied early
There may also be a role for topical tacrolimus and phototherapy, although caution needs to be exercised with light-skinned patients
Improve
References
DermNet NZ - Vitiligo
Dermatology
Vitiligo